Payments to Acquire Property, Plant, and Equipment of Amylyx Pharmaceuticals, Inc. from 31 Mar 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Amylyx Pharmaceuticals, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2021 to 31 Dec 2025.
  • Amylyx Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $11,000, a 84% decline year-over-year.
  • Amylyx Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $138,000, a 12% decline from 2024.
  • Amylyx Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $157,000, a 87% decline from 2023.
  • Amylyx Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,241,000, a 51% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Amylyx Pharmaceuticals, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $138,000 -$19,000 -12% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $157,000 -$1,084,000 -87% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $1,241,000 -$1,285,000 -51% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 $2,526,000 +$2,173,000 +616% 01 Jan 2022 31 Dec 2022 10-K 22 Feb 2024 2023 FY
2021 $353,000 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY

Amylyx Pharmaceuticals, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $11,000 -$56,000 -84% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $67,000 -$183,000 -73% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $250,000 -$92,000 -27% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $342,000 +$328,000 +2343% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $14,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.